Poster

Real-World Antipsychotic and Vesicular Monoamine Transporter Type 2 Inhibitor Treatment Patterns in Patients Newly Diagnosed With Tardive Dyskinesia

Antipsychotic (AP) and vesicular monoamine transporter type 2 inhibitor (VMAT2i) treatment patterns post-tardive dyskinesia (TD) diagnosis are unclear. Deutetrabenazine (DTBZ) is a VMAT2i...

10/26/2023

Real-World Antipsychotic Treatment Modification With and Without Deutetrabenazine in Patients Newly Diagnosed With Tardive Dyskinesia

Tardive dyskinesia (TD) management includes antipsychotic (AP) dose modification/discontinuation, often leaving underlying psychiatric conditions undertreated. Deutetrabenazine (DTBZ) is ...

10/26/2023

Real-World Effectiveness of Deutetrabenazine When Initiated Using a 4-Week Patient Titration Kit: Interim Results of the START Study

START is an ongoing, noninterventional, prospective, single-arm, 2-cohort (tardive dyskinesia [TD] and Huntington disease) study evaluating the effectiveness of deutetrabenazine initiated...

10/26/2023

Prevalence of Abnormal CYP2D6 Phenotypes in those with Treatment Resistant Depression

In a retrospective analysis of 356 patients, abnormal CYP2D6 variants were significantly more prevalent in those with treatment-resistant depression than those with other types of depress...

10/26/2023

Prevalence of concomitant medications among patients with schizophrenia prescribed atypical antipsychotics

The prevalence of concomitant medication use in patients with schizophrenia has not been well established. This study aimed to bridge this gap by evaluating the annual prevalence of conco...

10/26/2023

Qelbree® (viloxazine extended-release capsules): Final Results of the Long-Term, Phase 3, Open-Label Extension Trial in Adults With Attention-Deficit/Hyperactivity Disorder

Final results of a long-term, open-label extension of a pivotal phase 3 study leading to FDA-approval of viloxazine extended-release capsules (Qelbree®) in adults.

10/26/2023

Qualitative Study to Assess the Patient Perspective on Anhedonia Symptoms and Impacts in Major Depressive Disorder

This qualitative research study assessed the patient experience of anhedonia and its impacts among patients with MDD. Semi-structured concept elicitation interviews were conducted with 1...

10/26/2023

Rapid Relief of Complicated Grief State in a Marital Dyad By Application of Ketamine-facilitated Couples Psychotherapy

Psychedelic therapy was offered to a couple 'cognitively stuck' on their dyadic journey through their grief work. On, their second mutual ketamine-experience they both entered the transp...

10/26/2023

Preferences for Selecting and Initiating Long-Acting Injectable Antipsychotics: A Survey of US Psychiatric Clinicians (Results from the DECIDE Survey)

Clinician perspectives on the use of long-acting injectable antipsychotics (LAIs) for the treatment of schizophrenia are central to understanding real-world barriers to LAI use. In this s...

10/26/2023

Premature Ejaculation, And The Phycological Impact Of Majority Of Female Sexual Dysfunction

We aim to investigate the elevated occurrence of Female Orgasmic Disorder (FOD) within our patient population, attributable to male sexual dysfunction (MSD) in their partners. Through a c...

10/26/2023